Efecto de la avena y/o Lovastatina sobre el perfil lipídico en pacientes dislipidémicos del hospital de Tunjuelito, Bogotá 2008-2009

It has been postulated that diets rich in fiber are useful to reduce cardiovascular risk. Among the most commonly used lipid-lowering drugs are statins, fibrates, and in 1997 the FDA approved oats This research aimed to determine the effect of oats and lovastatin on lipid profile of dyslipidemic patients. The patient sample consisted of a total of 84 with dyslipidemia Tunjuelito hospital in Bogota. Were randomized and drug administration was conducted in randomly. Group 1 was administered Oats (A), 29 cases (34.5%). Lovastatin+Avena Group 2 (A + L), 22 cases (26.2%) and Group 3 Lovastatin (L), 33 cases (39.3%). They were followed for 12 weeks. The data were processed using SPSS. BMI showed no differences in group 1, being more significant in group 2 than in group 3. Waist circumference evidenced significant differences in the three groups. Cholesterol showed significant differences between group 1 and 3. Triglycerides showed significance in groups 2 and 3. This study provides evidence that dyslipidemic patients benefit by adding a natural product like oatmeal on abdominal circumference parameters and cholesterol.

• Autores: Alarcón Galeano, Aura Mónica; Buitrago Hernández, Diego Felipe; Romero Fierro, Laura Angélica; Sánchez Leyva, Ana María; Onatra H., William; Ríos, María Teresa
• Tipo de recurso: Article of journal
• Fecha de publicación: 2013
• Institución: Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
• Repositorio: Repositorio Institucional UDCA
• Idioma: spa
• OAI Identifier: oai:repository.udca.edu.co:11158/1743
• Acceso en línea: https://revistas.udca.edu.co/index.php/ruadc/article/view/903
• Palabra clave: Hipolipemiante; Fibratos; Perímetro abdominal; Colesterol; Avena; Colesterol
• Rights: openAccess
• License: Derechos Reservados - Universidad de Ciencias Aplicadas y Ambientales, 2013